Macugen is another drug with antiproliferative effects. This drug works similarly to Lucentis. It attacks vascular endothelial growth factor (VEGF) — the proteins which cause the blood vessels to grow.
Studies show similar results when using this drug, to the drug as mentioned earlier — neither being superior to the other.
This drug is also given through an injection into the eye, and it is usually administered every six weeks.
Up to 40 percent of patients given this type of treatment experience side effects such as eye floaters and discomfort.

This site offers information designed for educational purposes only. You should not rely on any information on this site as a substitute for professional medical advice, diagnosis, treatment, or as a substitute for, professional counseling care, advice, diagnosis, or treatment. If you have any concerns or questions about your health, you should always consult with a physician or other healthcare professional.